{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T05:31:05Z","timestamp":1768800665355,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10461-022-03851-x","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T15:32:07Z","timestamp":1668180727000},"page":"1140-1153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2078-2826","authenticated-orcid":false,"given":"Lucas","family":"Wiessing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Sypsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. O.","family":"Abagiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Arble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Berndt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Buskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Chemtob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Conyngham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Feelemyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hatzakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. E.","family":"Patrascu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Menza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Merrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Rademaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Revivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rosca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Seguin-Devaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Tinsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wilberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Des Jarlais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"3851_CR1","unstructured":"WHO. Weekly epidemiological update on COVID-19 - 11 May 2022. Geneva; 2022. Available from: https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---11-may-2022"},{"key":"3851_CR2","unstructured":"WHO. 14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021. Geneva; 2022. Available from: https:\/\/www.who.int\/news\/item\/05-05-2022-14.9-million-excess-deaths-were-associated-with-the-covid-19-pandemic-in-2020-and-2021"},{"key":"3851_CR3","unstructured":"United Nations. A UN framework for the immediate socio-economic response to COVID-19. April 2020. New York; 2020. Available from: https:\/\/unsdg.un.org\/sites\/default\/files\/2020-04\/UN-framework-for-the-immediate-socio-economic-response-to-COVID-19.pdf"},{"issue":"12","key":"3851_CR4","doi-asserted-by":"publisher","first-page":"e1192-e207","DOI":"10.1016\/S2214-109X(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192-e207.","journal-title":"Lancet Glob Health"},{"issue":"9719","key":"3851_CR5","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","volume":"375","author":"BM Mathers","year":"2010","unstructured":"Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375(9719):1014\u201328.","journal-title":"Lancet"},{"issue":"12","key":"3851_CR6","doi-asserted-by":"publisher","first-page":"e1208-e20","DOI":"10.1016\/S2214-109X(17)30373-X","volume":"5","author":"S Larney","year":"2017","unstructured":"Larney S, Peacock A, Leung J, Colledge S, Hickman M, Vickerman P, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Glob Health. 2017;5(12):e1208-e20.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"3851_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12954-017-0141-6","volume":"14","author":"L Wiessing","year":"2017","unstructured":"Wiessing L, Ferri M, Belackova V, Carrieri P, Friedman SR, Folch C, et al. Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study. Harm Reduct J. 2017;14(1):19.","journal-title":"Harm Reduct J"},{"issue":"9","key":"3851_CR8","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/j.1360-0443.2008.02465.x","volume":"104","author":"DC Des Jarlais","year":"2009","unstructured":"Des Jarlais DC, McKnight C, Goldblatt C, Purchase D. Doing harm reduction better: syringe exchange in the United States. Addiction. 2009;104(9):1441\u20136.","journal-title":"Addiction"},{"issue":"9","key":"3851_CR9","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/j.1360-0443.2009.02602.x","volume":"104","author":"L Maher","year":"2009","unstructured":"Maher L, Iversen J. Syringe exchange in the United States: doing the simple things better? Addiction. 2009;104(9):1448\u201350.","journal-title":"Addiction"},{"issue":"1","key":"3851_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1940-0640-7-10","volume":"7","author":"PD Friedmann","year":"2012","unstructured":"Friedmann PD, Schwartz RP. Just call it \u201ctreatment\u201d. Addict Sci Clin Pract. 2012;7(1):10.","journal-title":"Addict Sci Clin Pract"},{"key":"3851_CR11","unstructured":"WHO, UNODC, UNAIDS. WHO, UNODC, UNAIDS Technical Guide For Countries To Set Targets For Universal Access To HIV Prevention, Treatment And Care For Injecting Drug Users \u2013 2012 Revision. Geneva; 2012. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/77969\/1\/9789241504379_eng.pdf?ua=1"},{"key":"3851_CR12","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.","journal-title":"BMJ"},{"issue":"7","key":"3851_CR13","doi-asserted-by":"publisher","first-page":"e25583","DOI":"10.1002\/jia2.25583","volume":"23","author":"TI Vasylyeva","year":"2020","unstructured":"Vasylyeva TI, Smyrnov P, Strathdee S, Friedman SR. Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks. J Int AIDS Soc. 2020;23(7):e25583.","journal-title":"J Int AIDS Soc"},{"key":"3851_CR14","doi-asserted-by":"crossref","unstructured":"Baillargeon J, Polychronopoulou E, Kuo YF, Raji MA. The Impact of Substance Use Disorder on COVID-19 Outcomes. Psychiatric services (Washington, DC). 2021;72(5):578\u201381.","DOI":"10.1176\/appi.ps.202000534"},{"issue":"6","key":"3851_CR15","doi-asserted-by":"publisher","first-page":"e434-e42","DOI":"10.1016\/S2352-3018(20)30082-5","volume":"7","author":"DC Des Jarlais","year":"2020","unstructured":"Des Jarlais DC, Sypsa V, Feelemyer J, Abagiu AO, Arendt V, Broz D, et al. HIV outbreaks among people who inject drugs in Europe, North America, and Israel. Lancet HIV. 2020;7(6):e434-e42.","journal-title":"Lancet HIV"},{"issue":"Suppl 5","key":"3851_CR16","first-page":"239-s49","volume":"222","author":"SB Lyss","year":"2020","unstructured":"Lyss SB, Buchacz K, McClung RP, Asher A, Oster AM. Responding to Outbreaks of Human Immunodeficiency Virus Among Persons Who Inject Drugs-United States, 2016\u20132019: Perspectives on Recent Experience and Lessons Learned. J Infect Dis. 2020;222(Suppl 5):239-s49.","journal-title":"J Infect Dis"},{"issue":"40","key":"3851_CR17","doi-asserted-by":"publisher","first-page":"pii = 30036","DOI":"10.2807\/1560-7917.ES.2015.20.40.30036","volume":"20","author":"C Giese","year":"2015","unstructured":"Giese C, Igoe D, Gibbons Z, Hurley C, Stokes S, McNamara S, et al. Injection of new psychoactive substance snow blow associated with recently acquired HIV infections among homeless people who inject drugs in Dublin, Ireland, 2015. Euro Surveill. 2015;20(40):pii = 30036.","journal-title":"Euro Surveill"},{"issue":"36","key":"3851_CR18","doi-asserted-by":"publisher","first-page":"pii = 19962","DOI":"10.2807\/ese.16.36.19962-en","volume":"16","author":"D Paraskevis","year":"2011","unstructured":"Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, Antoniadou A, Lazanas M, et al. HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill. 2011;16(36):pii = 19962.","journal-title":"Euro Surveill"},{"issue":"11","key":"3851_CR19","doi-asserted-by":"publisher","first-page":"e78941","DOI":"10.1371\/journal.pone.0078941","volume":"8","author":"D Paraskevis","year":"2013","unstructured":"Paraskevis D, Nikolopoulos G, Fotiou A, Tsiara C, Paraskeva D, Sypsa V, et al. Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal study. PLoS ONE. 2013;8(11):e78941.","journal-title":"PLoS ONE"},{"issue":"9","key":"3851_CR20","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/add.12999","volume":"110","author":"A Hatzakis","year":"2015","unstructured":"Hatzakis A, Sypsa V, Paraskevis D, Nikolopoulos G, Tsiara C, Micha K, et al. Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. Addiction. 2015;110(9):1453\u201367.","journal-title":"Addiction"},{"issue":"1","key":"3851_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2105\/AJPH.2013.301656","volume":"105","author":"V Sypsa","year":"2015","unstructured":"Sypsa V, Paraskevis D, Malliori M, Nikolopoulos GK, Panopoulos A, Kantzanou M, et al. Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece. Am J Public Health. 2015;105(1):196\u2013204.","journal-title":"Am J Public Health"},{"issue":"10","key":"3851_CR22","first-page":"1496","volume":"215","author":"V Sypsa","year":"2017","unstructured":"Sypsa V, Psichogiou M, Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, et al. Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens. J Infect Dis. 2017;215(10):1496\u2013505.","journal-title":"J Infect Dis"},{"issue":"5","key":"3851_CR23","doi-asserted-by":"publisher","first-page":"e0215570","DOI":"10.1371\/journal.pone.0215570","volume":"14","author":"V Arendt","year":"2019","unstructured":"Arendt V, Guillorit L, Origer A, Sauvageot N, Vaillant M, Fischer A, et al. Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg. PLoS ONE. 2019;14(5):e0215570.","journal-title":"PLoS ONE"},{"key":"3851_CR24","doi-asserted-by":"crossref","unstructured":"Golden MR, Lechtenberg R, Glick SN, Dombrowski J, Duchin J, Reuer JR, et al. Outbreak of Human Immunodeficiency Virus Infection Among Heterosexual Persons Who Are Living Homeless and Inject Drugs - Seattle, Washington, 2018. MMWR Morbidity and mortality weekly report. 2019;68(15):344\u20139.","DOI":"10.15585\/mmwr.mm6815a2"},{"issue":"5","key":"3851_CR25","doi-asserted-by":"publisher","first-page":"e315-e24","DOI":"10.1016\/S2352-3018(19)30036-0","volume":"6","author":"A McAuley","year":"2019","unstructured":"McAuley A, Palmateer NE, Goldberg DJ, Trayner KMA, Shepherd SJ, Gunson RN, et al. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis. The Lancet HIV. 2019;6(5):e315-e24.","journal-title":"The Lancet HIV"},{"issue":"5","key":"3851_CR26","doi-asserted-by":"publisher","first-page":"e274-e5","DOI":"10.1016\/S2352-3018(19)30079-7","volume":"6","author":"V Sypsa","year":"2019","unstructured":"Sypsa V. Why do HIV outbreaks re-emerge among people who inject drugs? Lancet HIV. 2019;6(5):e274-e5.","journal-title":"Lancet HIV"},{"issue":"48","key":"3851_CR27","doi-asserted-by":"publisher","first-page":"pii = 20031","DOI":"10.2807\/ese.16.48.20031-en","volume":"16","author":"L Wiessing","year":"2011","unstructured":"Wiessing L, Likatavicius G, Hedrich D, Guarita B, van de Laar MJ, Vicente J. Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010. Euro Surveill. 2011;16(48):pii = 20031.","journal-title":"Euro Surveill"},{"issue":"4","key":"3851_CR28","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3390\/ijerph19042230","volume":"19","author":"RS Bolinski","year":"2022","unstructured":"Bolinski RS, Walters S, Salisbury-Afshar E, Ouellet LJ, Jenkins WD, Almirol E, et al. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings. Int J Environ Res Public Health. 2022;19(4):2230.","journal-title":"Int J Environ Res Public Health"},{"key":"3851_CR29","doi-asserted-by":"publisher","first-page":"109263","DOI":"10.1016\/j.drugalcdep.2021.109263","volume":"232","author":"KMA Trayner","year":"2022","unstructured":"Trayner KMA, McAuley A, Palmateer NE, Yeung A, Goldberg DJ, Glancy M, et al. Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study. Drug Alcohol Depend. 2022;232:109263.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"3851_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12954-021-00568-3","volume":"18","author":"Y Aponte-Melendez","year":"2021","unstructured":"Aponte-Melendez Y, Mateu-Gelabert P, Fong C, Eckhardt B, Kapadia S, Marks K. The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services. Harm Reduct J. 2021;18(1):118.","journal-title":"Harm Reduct J"},{"issue":"5","key":"3851_CR31","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s10900-021-00979-0","volume":"46","author":"CB Mistler","year":"2021","unstructured":"Mistler CB, Curley CM, Rosen AO, El-Krab R, Wickersham JA, Copenhaver MM, et al. The Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals. J Community Health. 2021;46(5):960\u20136.","journal-title":"J Community Health"},{"key":"3851_CR32","unstructured":"Public Health England, Health Protection Scotland, Public Health Wales, Public Health Agency Northern Ireland. Shooting Up: infections and other injecting-related harms among people who inject drugs in the UK, 2020 - an update December 2021. London; 2022 11\/2016. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1053202\/Shooting_Up_2021_report_final.pdf"},{"key":"3851_CR33","doi-asserted-by":"crossref","unstructured":"Roussos S, Paraskevis D, Psichogiou M, Kostaki EG, Flountzi E, Angelopoulos T, et al. Ongoing HIV transmission following a large outbreak among people who inject drugs in Athens, Greece (2014-2020). Addiction. 2021.","DOI":"10.1101\/2021.06.24.21258830"},{"issue":"9","key":"3851_CR34","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1007\/s10461-020-02886-2","volume":"24","author":"SN Glick","year":"2020","unstructured":"Glick SN, Prohaska SM, LaKosky PA, Juarez AM, Corcorran MA, Des Jarlais DC. The Impact of COVID-19 on Syringe Services Programs in the United States. AIDS Behav. 2020;24(9):2466\u20138.","journal-title":"AIDS Behav"},{"key":"3851_CR35","doi-asserted-by":"publisher","first-page":"102851","DOI":"10.1016\/j.drugpo.2020.102851","volume":"83","author":"M Whitfield","year":"2020","unstructured":"Whitfield M, Reed H, Webster J, Hope V. The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England. Int J Drug Policy. 2020;83:102851.","journal-title":"Int J Drug Policy"},{"key":"3851_CR36","doi-asserted-by":"publisher","first-page":"102821","DOI":"10.1016\/j.drugpo.2020.102821","volume":"83","author":"TS Bartholomew","year":"2020","unstructured":"Bartholomew TS, Nakamura N, Metsch LR, Tookes HE. Syringe services program (SSP) operational changes during the COVID-19 global outbreak. Int J Drug Policy. 2020;83:102821.","journal-title":"Int J Drug Policy"},{"key":"3851_CR37","unstructured":"EMCDDA. EMCDDA trendspotter briefing. May 2020. Impact of COVID-19 on drug services and help-seeking in Europe. Luxembourg; 2020. Available from: https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/13073\/EMCDDA-Trendspotter-Covid-19_Wave-1-2.pdf"},{"key":"3851_CR38","unstructured":"EMCDDA & Europol. EU Drug Markets: Impact of COVID-19. Luxembourg; 2020. Available from: https:\/\/www.emcdda.europa.eu\/publications\/joint-publications\/eu-drug-markets-impact-of-covid-19_en"},{"key":"3851_CR39","unstructured":"EMCDDA & Europol. Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons. Luxembourg; 2021. Available from: https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/13745\/TD0321143ENN_002.pdf"},{"key":"3851_CR40","unstructured":"WHO. The impact of COVID-19 on mental, neurological and substance use services: results of a rapid assessment. Geneva; 2020. Available from: https:\/\/www.who.int\/publications\/i\/item\/978924012455"},{"key":"3851_CR41","unstructured":"Slemp C. WV Health Alert Network - Health Advisory #162 - Human Immunodeficiency Virus (HIV) Infections Among People Who Inject Drugs - Additional Area Seeing Increase, Others Vulnerable. West Virginia Department of Health and Human Resources, Bureau for Public Health; 2019. Available from: https:\/\/oeps.wv.gov\/healthalerts\/documents\/wv\/WVHAN_162.pdf"},{"key":"3851_CR42","unstructured":"Minnesota Department of Health. Health Advisory: HIV Outbreak in Persons Who Inject Drugs (PWID). Minnesota Department of Health; 2020. Available from: https:\/\/www.health.state.mn.us\/communities\/ep\/han\/2020\/feb3hiv.pdf"},{"key":"3851_CR43","unstructured":"Madoff L, Brown CM, Lo JJ, S\u00e1nchez S. Increase in newly diagnosed HIV infections among persons who inject drugs in Boston. Massachusetts Department of Public Health, Boston Public Health Commission; 2021. Available from: https:\/\/view.officeapps.live.com\/op\/view.aspx?src=https%3A%2F%2Fwww.mass.gov%2Fdoc%2Fjoint-mdph-and-bphc-clinical-advisory-hiv-transmission-through-injection-drug-use-in-boston-march-15-2021%2Fdownload"},{"key":"3851_CR44","unstructured":"CDC. HIV Cluster and Outbreak Detection and Response 2022. Available from: https:\/\/www.cdc.gov\/hiv\/programresources\/guidance\/cluster-outbreak\/index.html"},{"issue":"3","key":"3851_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/10503307.2018.1447708","volume":"28","author":"HM Levitt","year":"2018","unstructured":"Levitt HM. How to conduct a qualitative meta-analysis: Tailoring methods to enhance methodological integrity. Psychother research: J Soc Psychother Res. 2018;28(3):367\u201378.","journal-title":"Psychother research: J Soc Psychother Res"},{"issue":"2","key":"3851_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.15585\/mmwr.mm7102a4","volume":"71","author":"RB Hershow","year":"2022","unstructured":"Hershow RB, Wilson S, Bonacci RA, Deutsch-Feldman M, Russell OO, Young S, et al. Notes from the Field: HIV Outbreak During the COVID-19 Pandemic Among Persons Who Inject Drugs\u2014Kanawha County, West Virginia, 2019\u20132021. Morb Mortal Wkly Rep. 2022;71(2):66.","journal-title":"Morb Mortal Wkly Rep"},{"key":"3851_CR47","unstructured":"Sypsa V, Tsirogianni E, Trafali D, Tsiagka D, Gavalaki A, Papanikolaou Z, et al. Estimated HIV prevalence and incidence among people who inject drugs in Thessaloniki, Greece (ALEXANDROS program). 11th IAS Conference on HIV Science, 18\u201321 July 2021 (virtual); 2021."},{"issue":"6","key":"3851_CR48","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s11524-020-00484-0","volume":"97","author":"N Glober","year":"2020","unstructured":"Glober N, Mohler G, Huynh P, Arkins T, O\u2019Donnell D, Carter J, et al. Impact of COVID-19 Pandemic on Drug Overdoses in Indianapolis. J Urban Health: Bull New York Acad Med. 2020;97(6):802\u20137.","journal-title":"J urban health: Bull New York Acad Med"},{"key":"3851_CR49","doi-asserted-by":"publisher","first-page":"108176","DOI":"10.1016\/j.drugalcdep.2020.108176","volume":"214","author":"S Slavova","year":"2020","unstructured":"Slavova S, Rock P, Bush HM, Quesinberry D, Walsh SL. Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend. 2020;214:108176.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"3851_CR50","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s11524-020-00486-y","volume":"97","author":"LN Rodda","year":"2020","unstructured":"Rodda LN, West KL, LeSaint KT. Opioid Overdose-Related Emergency Department Visits and Accidental Deaths during the COVID-19 Pandemic. J Urban Health: Bull New York Acad Med. 2020;97(6):808\u201313.","journal-title":"J urban health: Bull New York Acad Med"},{"key":"3851_CR51","doi-asserted-by":"crossref","unstructured":"Friedman J, Akre S. COVID-19 and the Drug Overdose Crisis: Uncovering the Deadliest Months in the United States, January\u2013July 2020. Am J Public Health. 2021:e1-e8.","DOI":"10.2105\/AJPH.2021.306256"},{"issue":"16","key":"3851_CR52","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1001\/jama.2020.17477","volume":"324","author":"TA Ochalek","year":"2020","unstructured":"Ochalek TA, Cumpston KL, Wills BK, Gal TS, Moeller FG. Nonfatal Opioid Overdoses at an Urban Emergency Department During the COVID-19 Pandemic. JAMA. 2020;324(16):1673\u20134.","journal-title":"JAMA"},{"key":"3851_CR53","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1186\/s12889-015-2604-6","volume":"15","author":"A Uuskula","year":"2015","unstructured":"Uusk\u00fcla A, Raag M, Vorobjov S, R\u00fc\u00fctel K, Lyubimova A, Levina OS, et al. Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Jarve, Estonia. BMC Public Health. 2015;15:1255.","journal-title":"BMC Public Health"},{"key":"3851_CR54","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell J, Tanz LJ, Gladden RM, Davis NL, Bitting J. Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls - United States, 2019\u20132020. MMWR Morbidity and mortality weekly report. 2021;70(50):1740\u20136.","DOI":"10.15585\/mmwr.mm7050e3"},{"issue":"6","key":"3851_CR55","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2105\/AJPH.2008.141846","volume":"99","author":"L Wiessing","year":"2009","unstructured":"Wiessing L, Likatavicius G, Klempova D, Hedrich D, Nardone A, Griffiths P. Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users. Am J Public Health. 2009;99(6):1049\u201352.","journal-title":"Am J Public Health"},{"key":"3851_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drugpo.2019.07.038","volume":"74","author":"JS Chang","year":"2019","unstructured":"Chang JS, Behar E, Coffin PO. Narratives of people who inject drugs on factors contributing to opioid overdose. Int J Drug Policy. 2019;74:26\u201332.","journal-title":"Int J Drug Policy"},{"key":"3851_CR57","doi-asserted-by":"crossref","unstructured":"Stack E, Leichtling G, Larsen JE, Gray M, Pope J, Leahy JM, et al. The Impacts of COVID-19 on Mental Health, Substance Use, and Overdose Concerns of People Who Use Drugs in Rural Communities. Journal of Addiction Medicine. 2020.","DOI":"10.1097\/ADM.0000000000000770"},{"key":"3851_CR58","doi-asserted-by":"publisher","first-page":"n913","DOI":"10.1136\/bmj.n913","volume":"373","author":"JW Tang","year":"2021","unstructured":"Tang JW, Marr LC, Li Y, Dancer SJ. Covid-19 has redefined airborne transmission. BMJ. 2021;373:n913.","journal-title":"BMJ"},{"issue":"1","key":"3851_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2105\/AJPH.2020.306015","volume":"111","author":"L Wiessing","year":"2021","unstructured":"Wiessing L, Seguin-Devaux C, Merendeiro CS. Could the COVID-19 Crisis Help Eradicate Chronic Homelessness? Am J Public Health. 2021;111(1):25\u20136.","journal-title":"Am J Public Health"},{"issue":"7","key":"3851_CR60","doi-asserted-by":"publisher","first-page":"536","DOI":"10.7326\/M20-3689","volume":"173","author":"J Del Amo","year":"2020","unstructured":"Del Amo J, Polo R, Moreno S, D\u00edaz A, Mart\u00ednez E, Arribas JR, et al. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study. Ann Intern Med. 2020;173(7):536\u201341.","journal-title":"Ann Intern Med"},{"issue":"13","key":"3851_CR61","doi-asserted-by":"publisher","first-page":"F3-f8","DOI":"10.1097\/QAD.0000000000002666","volume":"34","author":"YB Hadi","year":"2020","unstructured":"Hadi YB, Naqvi SFZ, Kupec JT, Sarwari AR. Characteristics and outcomes of COVID-19 in patients with HIV: a multicentre research network study. AIDS. 2020;34(13):F3-f8.","journal-title":"Aids"},{"issue":"11","key":"3851_CR62","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/jech-2020-214401","volume":"74","author":"C Bambra","year":"2020","unstructured":"Bambra C, Riordan R, Ford J, Matthews F. The COVID-19 pandemic and health inequalities. J Epidemiol Commun Health. 2020;74(11):964\u20138.","journal-title":"J Epidemiol Commun Health"},{"issue":"3","key":"3851_CR63","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1521\/aeap.16.3.250.35439","volume":"16","author":"SR Friedman","year":"2004","unstructured":"Friedman SR, Maslow C, Bolyard M, Sandoval M, Mateu-Gelabert P, Neaigus A. Urging others to be healthy: \u201cintravention\u201d by injection drug users as a community prevention goal. AIDS Educ prevention: official publication Int Soc AIDS Educ. 2004;16(3):250\u201363.","journal-title":"AIDS Educ prevention: official publication Int Soc AIDS Educ"},{"issue":"5","key":"3851_CR64","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3109\/10826084.2012.644107","volume":"47","author":"W Small","year":"2012","unstructured":"Small W, Wood E, Tobin D, Rikley J, Lapushinsky D, Kerr T. The Injection Support Team: a peer-driven program to address unsafe injecting in a Canadian setting. Subst Use Misuse. 2012;47(5):491\u2013501.","journal-title":"Subst Use Misuse"},{"key":"3851_CR65","doi-asserted-by":"publisher","first-page":"102958","DOI":"10.1016\/j.drugpo.2020.102958","volume":"83","author":"J Grebely","year":"2020","unstructured":"Grebely J, Cerd\u00e1 M, Rhodes T. COVID-19 and the health of people who use drugs: What is and what could be? Int J Drug Policy. 2020;83:102958.","journal-title":"Int J Drug Policy"},{"key":"3851_CR66","doi-asserted-by":"publisher","first-page":"108139","DOI":"10.1016\/j.jsat.2020.108139","volume":"119","author":"B Del Pozo","year":"2020","unstructured":"Del Pozo B, Rich JD. Revising our attitudes towards agonist medications and their diversion in a time of pandemic. J Subst Abuse Treat. 2020;119:108139.","journal-title":"J Subst Abuse Treat"},{"issue":"12","key":"3851_CR67","doi-asserted-by":"publisher","first-page":"e040556","DOI":"10.1136\/bmjopen-2020-040556","volume":"10","author":"D Crowley","year":"2020","unstructured":"Crowley D, Homeniuk R, Delargy I. Scoping review protocol: the use of telemedicine in providing opioid agonist treatment and related psychosocial supports. BMJ Open. 2020;10(12):e040556.","journal-title":"BMJ Open"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-022-03851-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-022-03851-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-022-03851-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:28:49Z","timestamp":1728347329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-022-03851-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["3851"],"URL":"https:\/\/doi.org\/10.1007\/s10461-022-03851-x","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"30 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Space has been included between the Spanish abstract and English abstract. In panels 1 and 2 the lines are updated and in Table 2, a header \u201cTOPIC AREA\u201d has been included before COVID-19 data.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None declared.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}